Akari Therapeutics Plc - AKTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Interim CFO | A | A | 1,000.0 | 13.0 | 13,000.0 | 20,452.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 7,353.0 | 3.74 | 27,500.22 | 19,452.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 3,725.0 | 3.49 | 13,000.25 | 12,099.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 2,539.0 | 5.12 | 12,999.68 | 8,374.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,570.0 | 8.28 | 12,999.6 | 5,835.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,395.0 | 9.32 | 13,001.4 | 4,265.0 | View | |
| Jun 25, 2026 | Interim CFO | A | A | 1,248.0 | 10.02 | 12,504.96 | 2,870.0 | View | |
| Jun 25, 2026 | CEO | A | A | 15,563.0 | 0.0 | 0.0 | 15,563.0 | View | |
| Jun 25, 2026 | CEO | A | A | 5,500.0 | 0.0 | 0.0 | 5,500.0 | View | |
| Mar 16, 2026 | — | P | A | 3,093.0 | 0.4041 | 1,249.88 | 3,093.0 | View | |
| Mar 16, 2026 | — | P | A | 3,093.0 | — | — | 3,093.0 | View | |
| Mar 16, 2026 | — | P | A | 2,473.0 | 0.4041 | 999.34 | 2,473.0 | View | |
| Mar 16, 2026 | — | P | A | 2,473.0 | — | — | 2,473.0 | View |